Patent Grant
11517760
The present invention is directed toward treating certain medical conditions using planar coils. More specifically, the present invention is directed toward the design, creation and use of clothing products, and other devices, that integrate configurations of arrays of planar coils to generate pulsed electromagnetic fields to treat various medical conditions, such as peripheral or diabetic neuropathies, damaged nerves, wounds, the effects of Parkinson's disease, neurodegenerative disorders, arthritis, cancer, wrinkles, and degenerated musculoskeletal tissues such as cartilage, bone, tendon and ligament.
Chronic pain affects more than 100 million people in the US. The most common underlying biological causes for chronic pain include decreased blood circulation, damaged nerves, and/or increased inflammation. While opioids have been a widely used way of alleviating chronic pain, the medical community now recognizes the substantial disadvantages of prescribing opioids. According to the National Institute of Health, more than 130 people in the United States die every day after overdosing on opioids, 21 to 29 percent of patients prescribed opioids for pain misuse them, and between 8 and 12 percent develop an opioid use disorder. The Centers for Disease Control and Prevention estimates that the total economic burden of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement. Therefore, the search is on for a better way to treat pain without relying on highly addictive drugs.
One conventional approach to treating pain is applying pulsing, low frequency electromagnetic fields (PEMF), non-invasively, to the area of the patient's skin where the patient is feeling pain. PEMF therapy uses bursts of low-level electromagnetic radiation to heal damaged tissues and bone and to relieve injury-related pain. The idea is that, when low frequency pulses pass through the skin and penetrate into muscle, nerves, bone and/or tendons, the body's natural repair mechanisms are activated, possibly by normalizing electrical charge distribution in cells, increasing blood perfusion in the affected areas, or improving signaling and/or conduction in nerves.
PEMF therapy has been shown to be effective in regenerating nerves, treating back pain, improving wound healing, countering the effects of Parkinson's disease, and treating peripheral neuropathy, using magnetic fields ranging from picoTesla to Tesla levels. PEMF is a recognized therapy for treating pseudoarthrosis, diabetes mellitus induced complications, delayed wound healing, pain and neurodegenerative disorders and arthritis, and for regenerating musculoskeletal tissues such as cartilage, bone, tendon and ligaments.
Conventionally, PEMF therapy is delivered by a mat, ring or a small disc device that generates a pulsing electromagnetic field using large cylindrically shaped, non-planar coils, such as Helmholtz coils or butterfly coils, where the winding or turns of the coils extend outward from the surface of the first coil in a Z axis. There are numerous disadvantages with these conventional devices. First, they are difficult to use for long periods of time because they require patients to either lay on a mat or strap a special bulky device to their body. Therefore, patient compliance is low and extended treatment periods, such as one or more hours, tends to be unrealistic for most active patients.
Second, they generate highly localized magnetic fields which tend to only over a small portion of the body or are substantially non-homogenous across their surface areas. As a result, the surface areas of the devices have regions with very low, non-therapeutic magnetic field dose levels interspersed with regions with sufficiently high, therapeutic doses of magnetic fields. Patients, however, are unaware of what surface areas emit therapeutic doses and what surface areas emit non-therapeutic doses, resulting in suboptimal therapy. For example, a patient with a need for PEMF therapy in his or her feet may lay on a mat in a way that the feet are not sufficiently exposed to the requisite magnetic field dose levels.
Third, for patients with extensive peripheral neuropathies, it is very difficult to get all over body PEMF therapy in an efficient manner. For example, a patient with pain all around his or her torso would have to lay on a mat in the right alignment with the surface areas emitting the right therapeutic doses, assuming such areas can be identified, for at least a period of time ranging from 20 minutes to 3 hours and then have to flip over and repeat the process. Again, this is highly inefficient for active patients.
Fourth, these devices are not specifically designed to treat, or be applied to, specific parts of the body. As such, they often fail to conform to particular body parts, are difficult to position or wear for long periods of time and are to use consistently.
Fifth, commercial PEMF devices, designed for at home use, to treat anxiety disorders, obsessive compulsive disorder, post-traumatic stress disorder, memory degeneration, schizophrenia, Parkinson's disease, stroke rehabilitation, drug addiction, including addiction to, or cravings for, nicotine, cocaine, alcohol, heroine, methamphetamines, stimulants, and/or sedatives, depression and depression-related conditions, such as post-partum depression or bipolar depression, auditory hallucinations, multiple sclerosis, fibromyalgia, Alzheimer's disease, spinocerebellar degeneration, epilepsy, urinary incontinence, movement disorders, chronic tinnitus, and sleep apnea are simply not available and have generally been deemed to be untreatable using PEMF devices.
It is therefore desirable to have a pulse electromagnetic field device that can generate substantially homogenous magnetic fields across large surface areas. It is further desirable to have a pulse electromagnetic field device that can be comfortably worn for long periods of time, thereby increasing patient compliance and allowing active patients to get the necessary treatment. It would also be desirable to have a pulse electromagnetic field device where the therapeutically effective dose regions are known and/or predictable. Finally, it would also be desirable to have a pulse electromagnetic field device designed to treat a wide range of disorders, particularly disorders with a locus of dysfunction in the brain.
The present specification discloses a pulsed electromagnetic field device comprising: an article of clothing; a controller removably attachable to the article of clothing; and a plurality of planar microcoil arrays, wherein each of the plurality of planar microcoil arrays comprises two or more planar microcoils positioned on a flexible substrate, wherein each of the plurality of planar microcoil arrays is integrated into the article of clothing; and wherein each of the plurality of planar microcoil arrays is in electrical communication with the controller.
Optionally, the pulsed electromagnetic field device further comprises a docking station, wherein the docking station is configured to releasably receive the controller. Optionally, the docking station comprises a first mechanical connector and a first electrical interface, wherein the controller comprises a second mechanical connector and a second electrical interface, and wherein, upon the first mechanical connector and the second mechanical connector latching, the first electrical interface is automatically placed in electrical communication with the second electrical interface.
Optionally, the article of clothing comprises two or more layers of material and the plurality of planar microcoil arrays is positioned between the two or more layers of material.
Optionally, the article of clothing is at least one of a sock, a shoe, a shirt, a pant, a glove, a mask, a neck covering, a head covering, a headband, a sleeve, or a brace configured to fit over an elbow, an ankle, or a knee.
Optionally, the controller is configured to generate a pulse train, wherein each pulse train comprises a plurality of pulses having an amplitude in a range of 1 mA to 200 mA. Optionally, the pulse train comprises a first pulse having a first amplitude, a second pulse having a second amplitude, and a third pulse having a third amplitude, wherein the first amplitude is less than the second amplitude and the second amplitude is less than the third amplitude. Each of the first pulse, second pulse, and third pulse may have a square shape. Each of the two or more planar microcoils may be configured to generate a magnetic field in a range of 1 microTesla to 100 microTesla upon receiving the pulse train.
Optionally, each of the plurality of planar microcoil arrays comprises at least six planar microcoils. Each of the plurality of planar microcoil arrays may comprise an input terminal configured to receive current from the controller, an output terminal, and at least two traces to electrically connect each of the at least six planar microcoils to the input terminal and the output terminal. Optionally, a first set of the at least six planar microcoils is configured to direct current clockwise and a second set of the at least six planar microcoils is configured to direct current counterclockwise. Optionally, the first set of the at least six planar microcoils is less than the second set of the at least six planar microcoils. Optionally, the first set of the at least six planar microcoils is equal to the second set of the at least six planar microcoils. All of the at least six planar microcoils may be configured to direct current in a same direction.
Optionally, each of the two or more planar microcoils is at least one of a spiral circular planar microcoil, a rectangular circular planar microcoil, a non-spiral circular planar microcoil, or a non-spiral rectangular planar microcoil.
Optionally, each of the plurality of planar microcoil arrays is physically separate and a first subset of the plurality of planar microcoil arrays has a different surface area than a second subset of the plurality of planar microcoil arrays.
Optionally, each of the plurality of planar microcoil arrays is physically separate and has a same surface area.
The controller may be configured to generate a time varying current in order to create a time varying magnetic field at each of the plurality of planar microcoil arrays. Optionally, the time varying current is defined by square waves having substantially equal peak amplitude values. Optionally, the time varying current is defined by sinusoidal waves having substantially equal peak amplitude values. Optionally, the time varying current is defined by square waves having substantially different peak amplitude values. Optionally, the time varying current is defined by a train of square waves wherein, in each train, the square waves have peak values that ramp from a low peak amplitude value to a higher peak amplitude value.
The controller may be configured to cause an electrical current to be concurrently transmitted to all of the plurality of planar microcoil arrays.
The controller may be configured to cause an electrical current to be transmitted to all of the plurality of planar microcoil arrays at different times.
Optionally, the pulsed electromagnetic field device further comprises a set of programmatic instructions stored on a separate computing device, wherein, when executed by the separate computing device, the programmatic instructions generate a display for prompting a user to input a pain level and a locus of pain. Optionally, when executed by the separate computing device, the programmatic instructions determine which of the plurality of planar microcoil arrays should receive an electrical current based on at least one of the pain level or the locus of pain.
Optionally, when executed by the separate computing device, the programmatic instructions generate data indicative of which of the plurality of planar microcoil arrays should receive an electrical current based on at least one of the pain level or the locus of pain and transmit the data to the controller. Optionally, the controller generates an electrical current based on the data and in a predefined pattern based on at least one of the pain level or the locus of pain.
Optionally, the pulsed electromagnetic field device further comprises a plurality of traces integrated into the article of clothing and extending from each of the plurality of planar microcoil arrays to the controller.
The present specification also discloses a method of treating a condition, comprising: attaching an article of clothing to a portion of a patient's body, wherein the article of clothing comprises a plurality of planar microcoil arrays, wherein each of the plurality of planar microcoil arrays comprises two or more planar microcoils positioned on a flexible substrate, wherein each of the plurality of planar microcoil arrays is integrated into the article of clothing; and wherein each of the plurality of planar microcoil arrays is in electrical communication with a docking station integrated into the article of clothing; attaching a controller to the docking station, wherein the controller comprises a circuit and a power source; and activating the controller to cause a time varying current to be transmitted to each of the plurality of planar microcoil arrays.
The method condition may be at least one of an anxiety disorder, an obsessive compulsive disorder, a post-traumatic stress disorder, memory degeneration, schizophrenia, Parkinson's disease, stroke rehabilitation, drug addiction, drug cravings, depression, depression-related conditions, post-partum depression, bipolar depression, auditory hallucinations, multiple sclerosis, fibromyalgia, Alzheimer's disease, spinocerebellar degeneration, epilepsy, urinary incontinence, movement disorders, chronic tinnitus, or sleep apnea.
Optionally, the method further comprises attaching the article of clothing such that at least one of the two or more planar microcoils in at least one of the plurality of planar microcoil arrays is positioned over an acupoint of the patient's body.
Optionally, upon attaching the controller to the docking station, the circuit automatically electrically interfaces with at least one of the plurality of planar microcoil arrays.
The present specification also discloses a pulsed electromagnetic field system comprising: a plurality of planar microcoil arrays, wherein each of the plurality of planar microcoil arrays comprises two or more planar microcoils positioned on a flexible substrate and wherein one of the plurality of planar microcoil arrays is connected to another of the plurality of planar microcoil arrays; and a controller configured to generate an electrical current and transmit that electrical current, in accordance with a particular stimulation protocol, to each of the plurality of planar microcoil arrays.
Optionally, the planar microcoil is at least one of a spiral circular planar microcoil, a rectangular circular planar microcoil, a non-spiral circular planar microcoil, or a non-spiral rectangular planar microcoil.
Optionally, a first subset of the plurality of planar microcoil arrays has a different surface area than a second subset of the plurality of planar microcoil arrays.
Optionally, each of the plurality of planar microcoil arrays has a same surface area.
Optionally, the stimulation protocol comprises a time varying magnetic field. Optionally, the time varying magnetic field is defined by square waves having substantially equal peak values. Optionally, the time varying magnetic field is defined by a sinusoidal wave. Optionally, the time varying magnetic field is defined by square waves having different peak values. Optionally, the time varying magnetic field is defined by a train of square waves wherein, in each train, the square waves have peak values that ramp from a low peak value to a higher peak value.
Optionally, the controller is configured to cause an electrical current to be transmitted substantially currently to all of the plurality of planar microcoil arrays.
Optionally, the controller is configured to cause an electrical current to be transmitted to the plurality of planar microcoil arrays at different times.
Optionally, the pulsed electromagnetic field system further comprises a set of programmatic instructions stored on a separate computing device, wherein, when executed by the separate computing device, the programmatic instructions generate a display for prompting a user to input a pain level and a locus of pain. Optionally, when executed by the separate computing device, the programmatic instructions determine which of the plurality of planar microcoil arrays should receive an electrical current based on the pain level and/or locus of pain. Optionally, when executed by the separate computing device, the programmatic instructions generate data indicative of which of the plurality of planar microcoil arrays should receive an electrical current based on the pain level and/or locus of pain and transmit said data to the controller. Optionally, the controller generates an electrical current based on said data and in a predefined pattern based on the pain level and/or locus of pain.
The present specification also discloses a sock, shirt, pant, glove, head covering, head band, helmet, mask, neck covering, sleeve, and garment comprising the pulsed electromagnetic field system described above.
The aforementioned and other embodiments of the present specification shall be described in greater depth in the drawings and detailed description provided below.
These and other features and advantages of the present specification will be further appreciated, as they become better understood by reference to the following detailed description when considered in connection with the accompanying drawings:
The present specification is directed towards multiple embodiments. The following disclosure is provided in order to enable a person having ordinary skill in the art to practice the invention. Language used in this specification should not be interpreted as a general disavowal of any one specific embodiment or used to limit the claims beyond the meaning of the terms used therein. The general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Also, the terminology and phraseology used is for the purpose of describing exemplary embodiments and should not be considered limiting. Thus, the present invention is to be accorded the widest scope encompassing numerous alternatives, modifications and equivalents consistent with the principles and features disclosed. For purpose of clarity, details relating to technical material that is known in the technical fields related to the invention have not been described in detail so as not to unnecessarily obscure the present invention.
In the description and claims of the application, each of the words “comprise” “include” and “have”, and forms thereof, are not necessarily limited to members in a list with which the words may be associated. It should be noted herein that any feature or component described in association with a specific embodiment may be used and implemented with any other embodiment unless clearly indicated otherwise.
As used herein, the indefinite articles “a” and “an” mean “at least one” or “one or more” unless the context clearly dictates otherwise.
As used herein, the term “planar coil” or “planar microcoil” both refer to a conductive pathway with curves or turns where the entirety of the conductive pathway is substantially positioned within the same plane. Stated differently, the turns, curves, or coils of the conductive pathway occupy varied positions within an X-Y plane but are of the same thickness or have a thickness within a range of 20% of each other. Accordingly, such a planar microcoil is differentiated from conventional coil structures because the windings or turns of the coil do not extend substantially upward or outward from the innermost or first coil in the Z direction or normal to the X-Y plane defined by the innermost or first coil. The terms “extend substantially upward or outward”, “within the same plane”, or “within the same X-Y plane” are defined as within +/−20 mm, within +/−15 mm, within +/−10 mm, or more preferably within +/−5 mm of a 0 point on the Z axis. The planar footprint area of a “planar coil” or “planar microcoil” is preferably greater than 1 cm2, more preferably between 1 cm2 and 9 cm2, and even more preferably between 2 cm2 and 4 cm2.
As used herein, the term “magnetic flux” refers to a quantity or strength of magnetic lines produced by a current passing through one or more planar coils and the term “magnetic flux density” refers to the amount of that magnetic flux in an area taken perpendicular to the magnetic flux's direction, typically measured in Tesla. It should be appreciated that, throughout this specification and in each embodiment taught here, all magnetic fields, and corresponding magnetic flux and magnetic flux densities, are generated by a current passing through one or more planar coils and are not generated by one or more permanent magnets unless otherwise stated. It should further be appreciated that each embodiment described herein may further include an optional version which expressly does not include, incorporate, or otherwise use permanent magnets but, yet, which still generate magnetic fields.
Planar Microcoil Structure
Referring to
Similarly,
It should be appreciated that the present invention is directed toward any spiral shaped planar microcoil, including polygonal, elliptical, or other shapes, having a plurality of turns where the conductive pathway follows a spiral shape from a first part of the circuit, or where the spiral coil conductive pathway begins, to a second part of the circuit, or where the spiral coil conductive pathway terminates. In such embodiments, each turn would form the same polygonal, elliptical, or other shape, except that the beginning and end of the shape are offset from each other, thereby creating a spiral across all turns. The spiral shaped conductive pathway would also be substantially entirely positioned within the same X-Y plane.
Similarly,
It should be appreciated that the present invention is directed toward any non-spiral shaped planar microcoil, including polygonal, elliptical, or other shapes, having a plurality of turns where the conductive pathway follows a polygonal, elliptical, or other shape from a first part of the circuit, or where the coil conductive pathway begins, to a second part of the circuit, or where the coil conductive pathway terminates. In such embodiments, each turn would form the same incomplete polygonal, elliptical, or other shape and would share a common electrical input and electrical output with the adjacent turns, thereby creating a set of nested incomplete polygonal, elliptical, or other shapes, each in electrical communication with a common electrical input and electrical output and each having a progressively smaller (or larger) length and width or radius. The conductive pathway of nested incomplete polygonal, elliptical, or other shapes would be substantially entirely positioned within the same X-Y plane
Table 1 has a list of preferred attributes of each of the spiral circular coil (
Referring back to
1. The coil, including any hard-plastic backing, has a footprint no greater than 2 cm by 2 cm, preferably no greater than 1.65 by 1.65 centimeters.
2. The coil comprises a plurality of wire turns, where the diameter of the coil in the plane of the coil is 0.04 mm.
3. The coil will have a minimum of 100 turns, preferably 175 windings, and even more preferably greater than 150 windings.
4. Each corner of the coil will have 1 quarter-circle with a radius of 0.18125 cm.
5. The inductance is in a range of 200 to 700 uH, preferably around 373 uH and the resistance is in a range of 50 to 800 ohms, preferably around 144 ohms.
6. The inner air core has dimensions in a range of 0.2 cm by 0.2 cm with each corner of the inner air core being 1 quarter-circle with a radius of 0.00625 cm.
Planar Microcoil Arrays and Controllers
Referring to
In one embodiment, the single patch 620 comprises two or more planar microcoils 615 or between 2 and 100 microcoils or more than 2 planar microcoils. In one embodiment, the set of patches used in any specific application, including in any piece of clothing, may have different sizes (e.g. surface areas), and therefore different numbers of planar microcoils, in order to better fit or suit different parts of a person's anatomy. For example, clothing positioned adjacent to the patient's torso may have larger patches, and more planar microcoils, integrated into a single patch than clothing positioned near the patient's toes or fingers, which may have smaller patches to better contour to the curves and crevices near the patient's toes or fingers, as further discussed in relation to
Controller 605 may be programmed to concurrently stimulate all the planar microcoils in all the patches, all planar microcoils on a subset of the patches, or a subset of planar microcoils on a subset of the patches. Further, the controller 605 may be optionally configured to removably interface with a docking station 675. Referring to
In one embodiment, programmatic instructions on a separate computing device, such as a phone, 635, are executed to capture pain data from the patient, analyze the pain data to determine which areas of the patient's anatomy requires pulsed electromagnetic field therapy, and, depending on the garment being worn by the patient, activate one or more planar microcoils on one or more patches to target the determined areas requiring pulsed electromagnetic field therapy.
More specifically, referring to
After receiving the user's response to the clearance questions, the app determines if there are any contraindications to use (i.e. a pacemaker, spinal implants, pins, or other implanted devices) 1310 and, depending upon the determination, generates an activation code which is transmitted to the controller 605. If the user inputted data is contraindicated for use with the specific piece of clothing, the app recommends the user first activate the device under the supervision of a physician. An override code, which would require the user to actively acknowledge the risks involved, may be provided by the app and either wirelessly transmitted to the controller 605 or displayed to the user who may manually input it into the controller 605.
If user, relative to the identified piece of clothing, is cleared for use and the controller 605 is activated, the app then prompts the user to input data indicative of the patient's pain level and location of the pain 1315. The app may do so by generating a visual analog scale that the user may use to indicate a level of pain being experienced (i.e. on a scale of 1 to 10 or using graphical emojis) and a graphical image of a human body, or portions thereof, to allow the user to identify, by pointing to the right location on the graphical image, the locus of pain. In one embodiment, the graphical image used is specific to the type of clothing identified using the original code indicative of the clothing acquired. Once the degree and/or locus of pain has been identified, the app may determine which set of patches and/or set of planar microcoils should be energized in order to treat the inputted level and location of pain 1320 and transmit such data to the controller. For other conditions, other questions may be posed, such as degree and timing of memory lapses, degree and timing of tremors, or degree and timing of other symptoms.
Referring to
Similarly, the output lead of each coil 1508 may be routed to one side of the array 1514 and may be kept separate from each other by one or more layers of insulation tape 1512. The output leads of all the coils 1508 of the array 1500 are integrated or multiplexed together to form an output terminal 1524 to which electrical current from the controller and energy source may be directed. Accordingly, the output leads of all the coils 1508 of the array 1500 are integrated or multiplexed together to form an output terminal 1524 to which electrical current may be directed from the array to the controller and energy source. Further, all the coils 1508 of the array 1500 may form a closed circuit by directing current from the array to the single energy or battery source via the one output terminal 1524.
Preferably, positioned between each coil piece 1504 or coil 1508 is a material that may act as a cushion, barrier, or padding 1518 that functions to both prevent the coil pieces from 1504 shifting and to gently position the array 1500 against the user's skin. Additionally, or alternatively, area 1518 may include an adhesive to attach, secure, or otherwise fixedly position the array 1500 against the user's skin. Additionally, or alternatively, area 1518 may include an attachment mechanism, such as Velcro or snaps, to attach area 1518, and therefore array 1500, to another substrate or material to form a piece of clothing, as further discussed below.
It should be appreciated that the directionality of the current of each coil may be modified to achieve a desired magnetic flux level by properly routing its input lead or output lead to the input or output side of the array 1500. Referring to
It should further be appreciated that the form factor and range of coil sizes and relative separation between coil pieces are important to achieving two core objectives. First, the coil footprint should not be too large, and the coil separation should not be too small, otherwise the array will not be flexible enough to conform to uneven or non-planar portions of a user's body. Second, the coil footprint should not be too small, and the coil separation should not be too large, otherwise the array will not generate a sufficiently large magnetic flux for therapeutic purposes. Hence, the dimensions and distances disclosed herein have a distinct utility and are not merely aesthetic in nature.
Stimulation Protocols
The controller is configured to generate an electrical current, and selectively transmit the electrical current to all of the plurality of planar microcoils, or a subset of the plurality of planar microcoils, in order to generate pulsed electromagnetic fields in accordance with one or more of
A stimulation session may go from 1 minute to 24 hours. As described above, within a given stimulations session, you may have a series of pulse bursts. A pulse burst may have one or more pulses. Each pulse in the pulse burst may have the same or different pulse shapes, as shown in
Controller Software
In one embodiment, the treatment systems disclosed herein, including the coils, coil arrays, and controller circuit configured to generate and deliver electrical current to the coils and coil arrays, are controlled by a software application configured to be installed and execute on a separate computing device, such as a mobile phone, laptop, or external controller, that is in wired or wireless communication with the controller circuit.
In one embodiment, the software application, or controller application, is configured to identify a type of coil system being used by a patient. Operationally, the controller application may be installed on a mobile phone and be configured to use a camera functionality of the mobile phone to capture a bar code, QR code, or other identification or be configured to generate a graphical user interface to receive an alphanumeric identifier of the coil system. Based on the data provided, the controller application may 1) validate the coil system as being a legitimate, authorized, or otherwise acceptable coil system, 2) determine what type of coil system is being used and whether that coil system is specific to a particular anatomical region, e.g. a coil system specific to a neck region, torso region, back region, leg region, foot region, arm region, head region, or other anatomical region, and 3) based upon that determination, generate graphical user interfaces that display anatomical regions specific to the coil system being used, e.g. if the coil system is specific to a neck region the generated graphical user interfaces visually display a neck, if the coil system is specific to a torso region the generated graphical user interfaces visually display a torso, if the coil system is specific to a back region the generated graphical user interfaces visually display a back region, if the coil system is specific to a leg region the generated graphical user interfaces visually display a leg region, if the coil system is specific to a foot region the generated graphical user interfaces visually display one or more feet, if the coil system is specific to an arm region the generated graphical user interfaces visually display one or more arms, and if the coil system is specific to a head region the generated graphical user interfaces (GUIs) visually display a head region.
In one embodiment, the generated GUIs are configured to receive an input from a patient as to a locus or loci of pain relative to the displayed anatomical region. For example, upon displaying the anatomical region in a GUI, a patient may paint, using a stylet or finger pressed upon a display, an area of the anatomical region that may be in pain. One or more GUIs may then be presented to prompt from a patient, and receive from the patient, an indication of the level of the pain via, for example, a visual analog scale where a user may indicate using numbers or icons a degree of the pain.
Based upon the highlighted anatomical region and the level of pain, the controller software determines 1) a desired level of magnetic flux to be delivered, 2) a corresponding set of coils to be energized in what order and at what frequency, and 3) a level of current to be delivered to each coil or coil array to generate the desired level of magnetic flux in the right location and at the right frequency. In particular, different locus or loci of pain may require an increased or decreased intensity or frequency of magnetic flux to be delivered at nerves located upstream or downstream from the locus or loci of pain. The controller software therefore comprises programmatic instructions, and supporting data, that correlates anatomical locations of pain with nerve areas that are co-located with the locus or loci of pain, upstream from the locus or loci of pain and/or downstream from the locus or loci of pain. In one embodiment, the controller software becomes aware of the location of specific coils or coil arrays based on at least one of 1) a preset relationship of the coils/coil arrays that is stored and known to the controller software based on identifying the type of coil system or 2) input by a user that indicates to the controller software where each of the coils are being positioned on a patient—such an indication being provided through a GUI that presents possible anatomical locations either through text or graphically.
In one embodiment, the software application, or controller application, is configured to generate instructions that, when communicated to and executed by the controller circuit, causes the controller circuit to generate electrical current and deliver that electrical current to different coils and/or coil arrays based on the desired frequency, intensity level, order, and location, as described above. For example, if a patient is suffering from acute pain on top of his or her right foot, the controller software may determine that coil arrays positioned on top of his or her right foot need to generate a magnetic flux in a range of 100 microTesla at a frequency of 10 Hz while coils positioned in the sole of the footwear, proximate the bottom of the patient's foot, need only be activated to generate a magnetic flux in a range of 20 microTesla at a frequency of 30 Hz.
In another embodiment, the controller circuit may be configured to electrically connect with a coil array or coils and upon making such a connection, to detect and store an identifier of the coil array or coil. The controller circuit preferably stores each of the identifiers and communicates it to the controller software upon connecting. These identifiers may be further used to identify the validity and/or type of coils or coil arrays being used.
To determine desired dosing levels, in another embodiment, the controller software may include a set of programmatic instructions for dose training. In one embodiment, the controller software operates in a training mode in which 1) a user is prompted to provide real-time feedback on pain levels using a visual analog scale, 2) the controller software modulates, over predefined periods of time, the frequency of pulse signals, the amount of current (and therefore magnetic flux intensity level) and/or the shape of the pulse signals in various combinations over the predefined period of time, and 3) as the parameters change, the user is prompted to input feedback on pain levels through the visual analog scale. For example, once a user identifies a locus of loci of pain, it initiates a cycling process starting with a set of frequency and modulating the current level and therefore the magnetic flux level up and down, prompting the user for feedback on pain levels during the cycling process. The controller software may then change frequency settings and repeat the up and down modulation of current level and magnetic flux level, again concurrently prompting the user for feedback on pain levels during the cycling process. Once the cycling processes are completed, the controller software analyzes the user's feedback to determine an optimal combination of frequency and current level for a given locus or loci of pain.
Integration of Planar Microcoils with Clothing
To improve patient compliance and provide for ease of use, the patches comprising planar microcoil arrays are integrated into clothing. Referring to
It should be appreciated that the array sizes may be variable. For example, as shown in each of the
It should further be appreciated that the planar microcoil arrays are preferably integrated into a layer of the clothing and are not directly exposed to the user's skin or to the outside environment. Referring to the shirt, head covering, foot covering, and hand coverings shown in
Footwear
In one embodiment, the present invention is directed toward the integration of coils and/or coil arrays into footwear, such as a shoe, boot, sock, or other foot covering. The sole or base of the footwear 1401 comprises a plurality of individual coils, such as Coil S1, Coil S2, and Coil S3, and/or coil arrays, such as Array S1 that are distributed on a surface of the sole or base. The individual coils, such as Coil S1, Coil S2, and Coil S3, and/or coil arrays, such as Array S1 may be of the type described herein or
Preferably, the individual coils, such as Coil S1, Coil S2, and Coil S3, and/or coil arrays, such as Array S1 are configured to be of different sizes with Coil S1 being larger or having more windings than Coil S2 or Coil S3 and where a distance between the Coil S1, Coil S2, and Coil S3 is between 1 cm and 3 cm, preferably around 2 cm. Each of the Coil S1, Coil S2, and Coil S3 are in electrical communication with the controller 1403. The controller 1403 is also in electrical communication with a plurality of coil arrays U1, U2, U3, U4, U5, and/or U6 1402 that are integrated into the upper of the footwear and configured to cover the entirety of the user's foot. As discussed above, each of the coil arrays may be energized and/or controller as described above to address a user's foot pain.
Optionally, the ankle region of the footwear device may comprise two large coils which are positioned on opposing sides of the ankle region and are spaced and sized to function as Helmholtz coils.
Referring to
Referring to
It should be appreciated that, upon activation, magnetic fields are generated in accordance with the stimulation protocols described above. Conventionally, it is believed that very large magnetic fields have to be directed into the brain to have any tangible therapeutic effects on certain conditions, such as depression. However, it is believed that, by modulating a position, configuration, orientation, or movement, of magnetite chains in one or more brain cells or neurons, which may be effectuated by magnetic fields less than 100 microTesla or by applying a sufficient magnetic field gradient, which is determined by the frequency and shape of pulse, one can cause a normalization of magnetite functionality, at least during the application of the magnetic fields. Normalization of magnetite functionality may thereby enable at least a partial alleviation of symptoms associated with anxiety disorders, obsessive compulsive disorder, post-traumatic stress disorder, memory degeneration, schizophrenia, Parkinson's disease, stroke rehabilitation, drug addiction, including addiction to, or cravings for, nicotine, cocaine, alcohol, heroine, methamphetamines, stimulants, and/or sedatives, depression and depression-related conditions, such as post-partum depression or bipolar depression, auditory hallucinations, multiple sclerosis, fibromyalgia, Alzheimer's disease, spinocerebellar degeneration, epilepsy, urinary incontinence, movement disorders, chronic tinnitus, or sleep apnea while the magnetic fields are being applied to the brain. Accordingly, it is within the scope of this invention to treat symptoms related to disorders having a loci of dysfunction in the brain by normalizing at least one of a position, configuration, orientation, or movement of magnetite chains in one or more brain cells or neurons by applying magnetic fields less than 100 microTesla or by applying a sufficient magnetic field gradient.
It should further be appreciated that other embodiments may be specifically designed to be directed toward 1) treating osteoporosis by, for example, positioning a plurality of arrays along a length of substrate configured to extend over an entire length of a user's spine, each of said arrays being in electrical communication with a controller, 2) effectuating an activation of acupoints that may be distributed over various areas of the user's body, where at each acupoint an array is positioned and where all of the arrays are in electrical communication with a controller; optionally, a coil that aligns with an acupoint may be configured to receive a higher level of current and generate a higher magnetic flux than the rest of the coils which are not aligned with an acupoint, 3) treating a neck region to reduce increase and increase a collagen framework, where a plurality of arrays are configured to extend around a neck region of the user, each of the arrays being in electrical communication with a controller, and 4) treating one or more broken bones by providing a plurality of arrays configured to be positioned on a user's skin and between a cast and the user's skin, each of the arrays being electrical communication with a controller.
Referring to
The condition is at least one of an anxiety disorder, an obsessive compulsive disorder, a post-traumatic stress disorder, memory degeneration, schizophrenia, Parkinson's disease, stroke rehabilitation, drug addiction, drug cravings, depression, depression-related conditions, post-partum depression, bipolar depression, auditory hallucinations, multiple sclerosis, fibromyalgia, Alzheimer's disease, spinocerebellar degeneration, epilepsy, urinary incontinence, movement disorders, chronic tinnitus, or sleep apnea.
The article of clothing may be attached such that at least one of the two or more planar microcoils in at least one of the plurality of planar microcoil arrays is positioned over an acupoint of the patient's body. Additionally, prior to attaching the article of clothing, a skin impedance measurement may be made and, based on the level of impedance, the article of clothing may be attached such that at least one of the two or more planar microcoils in at least one of the plurality of planar microcoil arrays is positioned over an area of impedance that exceeds a predefined threshold value. Accordingly, an impedance measurement sensor and circuit may also be integrated into the article of clothing.
While the exemplary embodiments of the present invention are described and illustrated herein, it will be appreciated that they are merely illustrative. It will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from or offending the spirit and scope of the invention.
The present application relies on U.S. Patent Provisional No. 62/892,751, entitled “Systems and Methods of Treating Medical Conditions Using Arrays of Planar Coils Configured to Generate Pulsed Electromagnetic Fields” and filed on Aug. 28, 2019, for priority. The present application also relies on U.S. Patent Provisional No. 62/843,727, entitled “Systems and Methods of Treating Medical Conditions Using Arrays of Planar Coils Configured to Generate Pulsed Electromagnetic Fields” and filed on May 6, 2019, for priority. Both applications are incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5368544 | Tran | Nov 1994 | A |
| 5470846 | Sandyk | Nov 1995 | A |
| 5691324 | Sandyk | Nov 1997 | A |
| 5691325 | Sandyk | Nov 1997 | A |
| 5885976 | Sandyk | Mar 1999 | A |
| 6267720 | Knox | Jul 2001 | B1 |
| 6561968 | Dissing | May 2003 | B1 |
| 7740574 | Pilla | Jun 2010 | B2 |
| 7744524 | Pilla | Jun 2010 | B2 |
| 7758490 | Pilla | Jul 2010 | B2 |
| 7896797 | Pilla | Mar 2011 | B2 |
| 8039031 | Baianu | Oct 2011 | B2 |
| 8262556 | Fischell | Sep 2012 | B2 |
| 8343027 | Dimino | Jan 2013 | B1 |
| 8415123 | Pilla | Apr 2013 | B2 |
| 8460167 | Chornenky | Jun 2013 | B2 |
| 8827886 | Chornenky | Sep 2014 | B2 |
| 8932196 | Chornenky | Jan 2015 | B2 |
| 8944985 | Bonmassar | Feb 2015 | B2 |
| 8961385 | Pilla | Feb 2015 | B2 |
| 9320913 | Dimino | Apr 2016 | B2 |
| 9403028 | Greff | Aug 2016 | B2 |
| 9410143 | Rudd | Aug 2016 | B1 |
| 9415233 | Pilla | Aug 2016 | B2 |
| 9427598 | Pilla | Aug 2016 | B2 |
| 9433797 | Pilla | Sep 2016 | B2 |
| 9440089 | Pilla | Sep 2016 | B2 |
| 9486638 | Chornenky | Nov 2016 | B2 |
| 9550067 | Fischell | Jan 2017 | B1 |
| 9656096 | Pilla | May 2017 | B2 |
| 9873000 | Moss | Jan 2018 | B2 |
| 9968797 | Sham | May 2018 | B2 |
| 10207122 | Pilla | Feb 2019 | B2 |
| 10226640 | Pilla | Mar 2019 | B2 |
| 10238867 | Ryaby | Mar 2019 | B2 |
| 10350428 | Pilla | Jul 2019 | B2 |
| 10398906 | Jin | Sep 2019 | B2 |
| 10413816 | Moir | Sep 2019 | B2 |
| 10426967 | Pilla | Oct 2019 | B2 |
| 10441807 | Moffett | Oct 2019 | B2 |
| 10471272 | Goetz | Nov 2019 | B2 |
| 10556121 | Gurfein | Feb 2020 | B2 |
| 10806942 | Hochstenbach | Oct 2020 | B2 |
| 20010047301 | Walker | Nov 2001 | A1 |
| 20020032667 | Walker | Mar 2002 | A1 |
| 20020035358 | Wang | Mar 2002 | A1 |
| 20020036367 | Walmer | Mar 2002 | A1 |
| 20020043301 | Walmer | Apr 2002 | A1 |
| 20020052634 | March | May 2002 | A1 |
| 20020066702 | Liu | Jun 2002 | A1 |
| 20020165583 | Tepper | Nov 2002 | A1 |
| 20020165771 | Walker | Nov 2002 | A1 |
| 20020188164 | Loos | Dec 2002 | A1 |
| 20030054888 | Walker | Mar 2003 | A1 |
| 20030094911 | Chukanov | May 2003 | A1 |
| 20030153965 | Supronowicz | Aug 2003 | A1 |
| 20030158583 | Burnett | Aug 2003 | A1 |
| 20030158585 | Burnett | Aug 2003 | A1 |
| 20030233122 | Azure | Dec 2003 | A1 |
| 20040034388 | Azure | Feb 2004 | A1 |
| 20040039639 | Walker | Feb 2004 | A1 |
| 20040116176 | Tulley | Jun 2004 | A1 |
| 20040140352 | Walker | Jul 2004 | A1 |
| 20040176803 | Whelan | Sep 2004 | A1 |
| 20040176805 | Whelan | Sep 2004 | A1 |
| 20040181115 | Sandyk | Sep 2004 | A1 |
| 20040210254 | Burnett | Oct 2004 | A1 |
| 20040241311 | Baianu | Dec 2004 | A1 |
| 20050024260 | Johnston | Feb 2005 | A1 |
| 20050043994 | Walker | Feb 2005 | A1 |
| 20050049640 | Gurtner | Mar 2005 | A1 |
| 20050084962 | Simon | Apr 2005 | A1 |
| 20050104768 | Johnston | May 2005 | A1 |
| 20050110837 | Silverbrook | May 2005 | A1 |
| 20050187012 | Walker | Aug 2005 | A1 |
| 20050220674 | Shafirstein | Oct 2005 | A1 |
| 20050271738 | Simon | Dec 2005 | A1 |
| 20060030896 | Simon | Feb 2006 | A1 |
| 20060052658 | Ozpapu | Mar 2006 | A1 |
| 20060057693 | Simon | Mar 2006 | A1 |
| 20060063963 | Brunelle | Mar 2006 | A1 |
| 20060129456 | Walker | Jun 2006 | A1 |
| 20060223616 | Tulley | Oct 2006 | A1 |
| 20060223617 | Tulley | Oct 2006 | A1 |
| 20060224456 | Walker | Oct 2006 | A1 |
| 20060229944 | Walker | Oct 2006 | A1 |
| 20060229945 | Walker | Oct 2006 | A1 |
| 20060241333 | Hunter | Oct 2006 | A1 |
| 20060241965 | Walker | Oct 2006 | A1 |
| 20060241966 | Walker | Oct 2006 | A1 |
| 20060246991 | Tulley | Nov 2006 | A1 |
| 20070010314 | Tulley | Jan 2007 | A1 |
| 20070026929 | Tulley | Feb 2007 | A1 |
| 20070050711 | Walker | Mar 2007 | A1 |
| 20070060477 | Pedersen | Mar 2007 | A1 |
| 20070066995 | Strother | Mar 2007 | A1 |
| 20070067004 | Boveja | Mar 2007 | A1 |
| 20070073773 | Walker | Mar 2007 | A1 |
| 20070073774 | Walker | Mar 2007 | A1 |
| 20070073775 | Walker | Mar 2007 | A1 |
| 20070104694 | Quijano | May 2007 | A1 |
| 20070105769 | Simon | May 2007 | A1 |
| 20070125851 | Walker | Jun 2007 | A1 |
| 20070167213 | Tulley | Jul 2007 | A1 |
| 20070167214 | Tulley | Jul 2007 | A1 |
| 20070167990 | Mangrum | Jul 2007 | A1 |
| 20070187539 | Hoppe | Aug 2007 | A1 |
| 20070282388 | Sandyk | Dec 2007 | A1 |
| 20080059318 | Packes, Jr. | Mar 2008 | A1 |
| 20080103558 | Wenzel | May 2008 | A1 |
| 20080125617 | Puchek | May 2008 | A1 |
| 20080201232 | Walker | Aug 2008 | A1 |
| 20080204021 | Leussler | Aug 2008 | A1 |
| 20080208663 | Walker | Aug 2008 | A1 |
| 20080217263 | Higgins | Sep 2008 | A1 |
| 20080229795 | Toeniskoetter | Sep 2008 | A1 |
| 20080249879 | Walker | Oct 2008 | A1 |
| 20080280826 | O'Connor | Nov 2008 | A1 |
| 20080288035 | Gill | Nov 2008 | A1 |
| 20080300912 | Packes, Jr. | Dec 2008 | A1 |
| 20090013583 | Leung | Jan 2009 | A1 |
| 20090163762 | Setti | Jun 2009 | A1 |
| 20090171417 | Philipson | Jul 2009 | A1 |
| 20090208598 | Novitsky | Aug 2009 | A1 |
| 20090224037 | Walker | Sep 2009 | A1 |
| 20090227831 | Burnett | Sep 2009 | A1 |
| 20090254531 | Walker | Oct 2009 | A1 |
| 20090299128 | Setti | Dec 2009 | A1 |
| 20090304542 | Sterling | Dec 2009 | A1 |
| 20090310331 | Leung | Dec 2009 | A1 |
| 20100049262 | Puchek | Feb 2010 | A1 |
| 20100057146 | Gleim | Mar 2010 | A1 |
| 20100121131 | Mathes | May 2010 | A1 |
| 20100160712 | Burnett | Jun 2010 | A1 |
| 20100185523 | Tulley | Jul 2010 | A1 |
| 20100210893 | Pilla | Aug 2010 | A1 |
| 20100211174 | Scarborough | Aug 2010 | A1 |
| 20100222630 | Mangrum | Sep 2010 | A1 |
| 20100233305 | Farzamfar | Sep 2010 | A1 |
| 20100239544 | Simon | Sep 2010 | A1 |
| 20100274177 | Rybski | Oct 2010 | A1 |
| 20110004261 | Sham | Jan 2011 | A1 |
| 20110065976 | Chornenky | Mar 2011 | A1 |
| 20110105959 | O'Connor | May 2011 | A1 |
| 20110112352 | Pilla | May 2011 | A1 |
| 20110124717 | O'Connor | May 2011 | A1 |
| 20110125287 | Hotter | May 2011 | A1 |
| 20110130618 | Ron Edoute | Jun 2011 | A1 |
| 20110152667 | Doerr | Jun 2011 | A1 |
| 20110152672 | Doerr | Jun 2011 | A1 |
| 20110152674 | Doerr | Jun 2011 | A1 |
| 20110152972 | Doerr | Jun 2011 | A1 |
| 20110207989 | Pilla | Aug 2011 | A1 |
| 20110248019 | Chew | Oct 2011 | A1 |
| 20110283607 | Gleim | Nov 2011 | A1 |
| 20110302161 | Walker | Dec 2011 | A1 |
| 20110313235 | Gleim | Dec 2011 | A1 |
| 20120010559 | Higgins | Jan 2012 | A1 |
| 20120064594 | Van Bree | Mar 2012 | A1 |
| 20120071235 | Walker | Mar 2012 | A1 |
| 20120101327 | Dissing | Apr 2012 | A1 |
| 20120116149 | Pilla | May 2012 | A1 |
| 20120143285 | Wang | Jun 2012 | A1 |
| 20120157747 | Rybski | Jun 2012 | A1 |
| 20120172653 | Chornenky | Jul 2012 | A1 |
| 20120184802 | Gleim | Jul 2012 | A1 |
| 20120191159 | Willeford | Jul 2012 | A1 |
| 20120205558 | Jindal | Aug 2012 | A1 |
| 20120209055 | Gleim | Aug 2012 | A1 |
| 20120330090 | Sham | Dec 2012 | A1 |
| 20120330771 | Walker | Dec 2012 | A1 |
| 20130035538 | Maestu Unturbe | Feb 2013 | A1 |
| 20130035539 | Kornstein | Feb 2013 | A1 |
| 20130062193 | Proudkii | Mar 2013 | A1 |
| 20130085317 | Feinstein | Apr 2013 | A1 |
| 20130158634 | Ron Edoute | Jun 2013 | A1 |
| 20130164736 | Bernardi | Jun 2013 | A1 |
| 20130178425 | Higgins | Jul 2013 | A1 |
| 20130211896 | Walker | Aug 2013 | A1 |
| 20130218700 | Walker | Aug 2013 | A1 |
| 20130238062 | Ron Edoute | Sep 2013 | A1 |
| 20130289433 | Jin | Oct 2013 | A1 |
| 20130317282 | Ron Edoute | Nov 2013 | A1 |
| 20130328552 | Chen | Dec 2013 | A1 |
| 20130334857 | Wolsiefer | Dec 2013 | A1 |
| 20140024882 | Chornenky | Jan 2014 | A1 |
| 20140046116 | Gleim | Feb 2014 | A1 |
| 20140072926 | Valoir | Mar 2014 | A1 |
| 20140081070 | Paukshto | Mar 2014 | A1 |
| 20140102947 | Baym | Apr 2014 | A1 |
| 20140152227 | Tuval | Jun 2014 | A1 |
| 20140155680 | Higgins | Jun 2014 | A1 |
| 20140171789 | Barth | Jun 2014 | A1 |
| 20140175330 | Black | Jun 2014 | A1 |
| 20140213843 | Pilla | Jul 2014 | A1 |
| 20140213844 | Pilla | Jul 2014 | A1 |
| 20140221726 | Pilla | Aug 2014 | A1 |
| 20140249354 | Anderson | Sep 2014 | A1 |
| 20140249355 | Martinez | Sep 2014 | A1 |
| 20140274893 | Woodell-May | Sep 2014 | A1 |
| 20140274894 | Leach | Sep 2014 | A1 |
| 20140274895 | Binder | Sep 2014 | A1 |
| 20140330067 | Jordan | Nov 2014 | A1 |
| 20140378812 | Saroka | Dec 2014 | A1 |
| 20150025299 | Ron Edoute | Jan 2015 | A1 |
| 20150141737 | Willeford | May 2015 | A1 |
| 20150151136 | Ruetenik | Jun 2015 | A1 |
| 20150198381 | Kuehl | Jul 2015 | A1 |
| 20150217125 | Chornenky | Aug 2015 | A1 |
| 20150297910 | Dimino | Oct 2015 | A1 |
| 20150300299 | Licitar | Oct 2015 | A1 |
| 20150306412 | Durschmidt | Oct 2015 | A1 |
| 20150315539 | Villanueva | Nov 2015 | A1 |
| 20150320697 | O'Connor | Nov 2015 | A1 |
| 20150328476 | Anderson | Nov 2015 | A1 |
| 20150342661 | Ron Edoute | Dec 2015 | A1 |
| 20150366999 | Amritphale | Dec 2015 | A1 |
| 20160038753 | Chornenky | Feb 2016 | A1 |
| 20160051827 | Ron Edoute | Feb 2016 | A1 |
| 20160074670 | Mohamed | Mar 2016 | A1 |
| 20160121135 | Pilla | May 2016 | A1 |
| 20160129273 | Park | May 2016 | A1 |
| 20160129274 | Park | May 2016 | A1 |
| 20160145571 | Giampapa | May 2016 | A1 |
| 20160220083 | Thorne | Aug 2016 | A1 |
| 20160228721 | Mohamed | Aug 2016 | A1 |
| 20160228723 | Mohamed | Aug 2016 | A1 |
| 20160346561 | Ron Edoute | Dec 2016 | A1 |
| 20160372362 | Signamarcheix | Dec 2016 | A1 |
| 20170001201 | Baym | Jan 2017 | A1 |
| 20170043177 | Ron Edoute | Feb 2017 | A1 |
| 20170050019 | Ron Edoute | Feb 2017 | A1 |
| 20170071977 | Mohamed | Mar 2017 | A1 |
| 20170072210 | Gangwish | Mar 2017 | A1 |
| 20170080245 | Dimino | Mar 2017 | A1 |
| 20170087367 | Weisend | Mar 2017 | A1 |
| 20170113060 | Anderson | Apr 2017 | A1 |
| 20170151442 | Walborn | Jun 2017 | A1 |
| 20170157318 | Balakrishnan | Jun 2017 | A1 |
| 20170165496 | Pilla | Jun 2017 | A1 |
| 20170175521 | Pirolli | Jun 2017 | A1 |
| 20170189710 | Goetz | Jul 2017 | A1 |
| 20170225004 | Casse | Aug 2017 | A1 |
| 20170266459 | Mohamed | Sep 2017 | A1 |
| 20170304642 | Ron Edoute | Oct 2017 | A1 |
| 20170354830 | Moffett | Dec 2017 | A1 |
| 20180001102 | Henry | Jan 2018 | A1 |
| 20180028831 | Ron Edoute | Feb 2018 | A1 |
| 20180043172 | Serrano Carmona | Feb 2018 | A1 |
| 20180043174 | Gurfein | Feb 2018 | A1 |
| 20180071140 | Sheydin | Mar 2018 | A1 |
| 20180104484 | Ryaby | Apr 2018 | A1 |
| 20180110960 | Youngblood | Apr 2018 | A1 |
| 20180126185 | Hochstenbach | May 2018 | A1 |
| 20180133498 | Chornenky | May 2018 | A1 |
| 20180140861 | Dimino | May 2018 | A1 |
| 20180200503 | Ryaby | Jul 2018 | A1 |
| 20180200531 | Pilla | Jul 2018 | A1 |
| 20180207439 | Cook | Jul 2018 | A1 |
| 20180272149 | Anderson | Sep 2018 | A1 |
| 20180318598 | Russo | Nov 2018 | A1 |
| 20180361144 | Omar-Pasha | Dec 2018 | A1 |
| 20190021277 | Godfrey | Jan 2019 | A1 |
| 20190054308 | Verma | Feb 2019 | A1 |
| 20190082990 | Poltorak | Mar 2019 | A1 |
| 20190091474 | Zeng | Mar 2019 | A1 |
| 20190126036 | Franco-Obregon | May 2019 | A1 |
| 20190201280 | Bak | Jul 2019 | A1 |
| 20190217090 | Ryaby | Jul 2019 | A1 |
| 20190247662 | Poltroak | Aug 2019 | A1 |
| 20190255363 | Gangwish | Aug 2019 | A1 |
| 20190290925 | Gellman | Sep 2019 | A1 |
| 20190296589 | Ardavan | Sep 2019 | A1 |
| 20190299018 | Chornenky | Oct 2019 | A1 |
| 20190323345 | Pirolli | Oct 2019 | A1 |
| 20190329065 | Gandel | Oct 2019 | A1 |
| 20190336782 | Shealy | Nov 2019 | A1 |
| 20190343702 | Smith | Nov 2019 | A1 |
| 20190351249 | Pilla | Nov 2019 | A1 |
| 20190365803 | Melosh | Dec 2019 | A1 |
| 20190381331 | Gleim | Dec 2019 | A1 |
| 20190388676 | Babico | Dec 2019 | A1 |
| 20200001101 | Moffett | Jan 2020 | A1 |
| 20200016422 | Ron Edoute | Jan 2020 | A1 |
| 20200016423 | Ron Edoute | Jan 2020 | A1 |
| 20200069960 | Walborn | Mar 2020 | A1 |
| 20200077942 | Youngblood | Mar 2020 | A1 |
| 20200094066 | Heath | Mar 2020 | A1 |
| 20200094068 | Dimino | Mar 2020 | A1 |
| 20200171318 | Dimino | Jun 2020 | A1 |
| 20200206523 | Kirk | Jul 2020 | A1 |
| 20200238098 | Chornenky | Jul 2020 | A1 |
| 20200276435 | Ryaby | Sep 2020 | A1 |
| 20200285131 | Marandi | Sep 2020 | A1 |
| 20200289841 | McIntyre | Sep 2020 | A1 |
| 20200306554 | Ron Edoute | Oct 2020 | A1 |
| 20200353274 | Ansari | Nov 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 1483487 | Mar 2004 | CN |
| 1723985 | Mar 2008 | EP |
| 100846091 | Jul 2008 | KR |
| 2004011631 | Feb 2004 | WO |
| 2004103098 | Dec 2004 | WO |
| 2010124234 | Oct 2010 | WO |
| 2011011748 | Jan 2011 | WO |
| 2012033932 | Mar 2012 | WO |
| 2012045079 | Apr 2012 | WO |
| 2015161063 | Oct 2015 | WO |
| 2016081952 | May 2016 | WO |
| 2018075394 | Apr 2018 | WO |
| 2020041502 | Feb 2020 | WO |
| 202118341 | Sep 2021 | WO |
| Entry |
|---|
| International Search Report for PCT/US21/30826, dated Sep. 8, 2021. |
| Written Opinion of the International Search Authority for PCT/US21/30826, dated Sep. 8, 2021. |
| Anthony J. Lisi et al., “A Pulsed Electromagnetic Field Therapy Device for Non-Specific Low Back Pain: A Pilot Randomized Controlled Trial”, Mar. 12, 2019, Pain Ther (2019) 8:133-140. |
| Sujith Vijayan et al., “Thalamic model of awake alpha oscillations and implications for stimulus processing”, PNAS Nov. 6, 2012 109 (45) 18553-18558. |
| Mingke Jiao et al., “Effects of Low-Frequency Pulsed Electromagnetic Fields on High-Altitude Stress Ulcer Healing in Rats”, Hindawi BioMed Research International, vol. 2019, Article ID 6354054, 8 pages. |
| Maria Vadala et al., “Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology”, Cancer Medicine 2016; 5(11):3128-3139. |
| Renate Gehwolf et al., “Global Responses of II-1β-Primed 3D Tendon Constructs to Treatment with Pulsed Electromagnetic Fields”, Published: Apr. 30, 2019, Cells 2019, 8(5), 399. |
| Pierre Le Chapellier et al., “Cellular Perception and Static Magnetic Fields Active Penetration Depth for Pain Magnetotherapy”, Piers Online, vol. 6, No. 3, 2010. |
| Tommaso Iannitti et al., “Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: clinical experience in the elderly”, Published Sep. 26, 2013, Clinical Interventions in Aging 2013:8 1289-1293. |
| Yvan Touitou et al., “The effects of extremely low-frequency magnetic fields on melatonin and cortisol, two marker rhythms of the circadian system”, Dialogues in Clinical Neuroscience—vol. 14. No. 4. 2012. |
| Alanna V Van Huizen et al., “Weak magnetic fields alter stem cell-mediated growth”, Sci Adv. Jan. 30, 2019;5(1):eaau7201. |
| Wenjun Xu et al., “Effect of pulsed millisecond current magnetic field on the proliferation of C6 rat glioma cells”, Electromagnetic Biology and Medicine, 2019, vol. 38, No. 3, 185-197. |
| Peter Kovacic et al., “Electromagnetic fields: mechanism, cell signaling, other bioprocesses, toxicity, radicals, antioxidants and beneficial effects”, Journal of Receptors and Signal Transduction, 2010; 30(4): 214-226. |
| Connie X. Wang et al., “Transduction of the Geomagnetic Field as Evidenced from alpha-Band Activity in the Human Brain”, eNeuro, Mar./Apr. 2019, 6(2) e0483-18.2019 1-23. |
| Christina L. Ross et al., “Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis”, Mar. 4, 2019, Frontiers in Immunology, vol. 10: Article 266. |
| Rachel Lai-Chu Kwan et al., “Efficacy of Biophysical Energies on Healing of Diabetic Skin Wounds in Cell Studies and Animal Experimental Models: A Systematic Review”, Jan. 16, 2019, Int. J. Mol. Sci. 2019, 20(2), 368. |
| Masoomeh Kazemi et al., “Effects of the Extremely Low Frequency Electromagnetic Fields on NMDA-Receptor Gene Expression and Visual Working Memory in Male Rhesus Macaques”, May, Jun. 2018, Basic and Clinical Neuroscience, 9(3), 167-176. |
| Yue Li et al., “Effects of pulsed electromagnetic fields on learning and memory abilities of STZ-induced dementia rats”, Mar. 17, 2019, Electromagnetic Biology and Medicine, 38:2, 123-130. |
| Igor Jerman et al., “Enhancing Vigilance by Low Intensity Transcranial Pulsed Magnetic Stimulation Applying the Entrainment Model”, Oct. 17, 2019, Open Access Library Journal, 6: e5782. |
| Igor Jerman et al., “Influencing Relaxation by a Low Intensity Transcranial Pulsed Magnetic Stimulation Applying the Entrainment Model”, Sep. 17, 2019, Open Access Library Journal, 6: e5741. |
| Laura Baker-Price et al., “Intermittent Burst-Firing Weak (1 Microtesla) Magnetic Fields Reduce Psychometric Depression in Patients who Sustained Closed Head Injuries: A Replication and Electroencephalographic Validation”, Perceptual and MotorSkils, 2003,96,965-974. |
| Kalina Makowiecki et al., “Low-intensity repetitive transcranial magnetic stimulation requires concurrent visual system activity to modulate visual evoked potentials in adult mice”, Apr. 11, 2018, Scientific Reports, vol. 8, Article No. 5792 (2018). |
| John A. Robertson, “Magnetic Field Effects on the Neuroprocessing of Pain”, Aug. 2011, Electronic Thesis and Dissertation Repository, Paper 236. |
| Mahtab Roohi-Azizi et al., “Changes of the brain's bioelectrical activity in cognition, consciousness, and some mental disorders”, Med J Islam Repub Iran. 2017(Sep. 3); 31.53. |
| G. Bard Ermentrout et al., “Modeling neural oscillations”, Sep. 6, 2002, Physiology & Behavior 77 (2002) 629-633. |
| Nermeen Mohamed Abdelhalim et al., “Short-Term impacts of pulsed electromagnetic field therapy in middle-aged university's employees with non-specific low back pain: A pilot study”, Pak J Med Sci. 2019; 35(4):987-991. |
| Rachel Lai-Chu Kwan et al., “Pulsed Electromagnetic Field Therapy Promotes Healing and Microcirculation of Chronic Diabetic Foot Ulcers: A Pilot Study”, May 2015, Advances in Skin & Wound Care, vol. 28, No. 5. |
| Magor L. Lörincz et al., “Temporal Framing of Thalamic Relay-Mode Firing by Phasic Inhibition during the Alpha Rhythm”, Neuron. Sep. 10, 2009; 63(5): 683-696. |
| Chul-Ho Kim et al., “The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome”, Aug. 8, 2019, Blood Pressure, 29:1, 47-54. |
| International Search Report for PCT/US20/31467, dated Aug. 31, 2020. |
| Written Opinion of the International Search Authority for PCT/US20/31467, dated Aug. 31, 2020. |
| OmniPENF—OmniPENF Distibutors; Become an Authorized Distributor. Contact page [online]. Cell Technologies, Inc.; Aug. 22, 2018 [retrieved on Feb. 2, 2022]. Retrieved from the Internet: <URL:https://web.archive.org/web/20180822093113/https://omnipemf.com/>. |
| OSKA Pulse Buy Now/How It Works; Doctor Recommended OSKA Pulse Clinically Proven Pain Relief. Purchase Page [online], Oska Wellness; Apr. 5, 2019 [retrived on Feb. 4, 2022], Retrieved from the Internet: <URL:https://web.archive.org/web/20190405101216/https://www.oskawellness.com/>. |
| Number | Date | Country | |
|---|---|---|---|
| 20200353274 A1 | Nov 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62892751 | Aug 2019 | US | |
| 62843727 | May 2019 | US |
